29
Participants
Start Date
May 5, 2020
Primary Completion Date
March 5, 2021
Study Completion Date
March 5, 2021
High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma
Pathogen reduced SARS-CoV-2 convalescent plasma (1-2 units; \~200 mL each for a total of 200-400mls) given preferably in one day, but allowable to be given over 2 days if clinical circumstances delay infusions in 1 day), with titer to be determined after the unit has been infused.
University of Virginia Medical Center, Charlottesville
University of Virginia, Charlottesville
University of Virginia
OTHER